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Oral contraceptives are pharmaceutical formulations
containing steroid hormones in a relatively small amount.
The most commonly encountered estrogen is ethinylestra-
diol (Fig. 1), present at a very low dosage level (30-100 μg
per tablet), in combination with an orally active synthetic
progestin (one of the most commonly used is levonorges-
trel (Fig. 2)), present at a level of 5 to 30 times that that of
the estrogen. Ethinylestradiol (EED) is a semi synthetic
estrogen female sex hormone and levonorgestrel (LNG) is
a synthetic steroid with an extremely potent progestational
action (1, 2, 3).
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Abstract
Oral contraceptives are pharmaceutical formulations containing an estrogen in a small amount and a synthetic progestin in 5-30
times bigger amount. A sensitive, accurate and rapid method for determination of active compounds is required. 
We have developed HPLC methods for determination of ethinylestradiol (EED) and levonorgestrel (LNG) in commercially avail-
able tablets. Chromatographic separation was performed on a Purospher® STAR RP-18e reversed-phase column (150 X 4.0 mm I.D.;
particle size 5 µm) in an isocratic mode with a mobile phase constituted of 47% acetonitrile: 53% water (V/V) for both methods. The
elution was carried out at a flow rate of 1.50 ml /min. All analyses were performed at room temperature (24 +/- 2°C). In the HPLC
method with UV detection (internal standard method) both compounds were detected at 215 nm. Drospirenone was used as an internal
standard. In HPLC method with UV/fluorescence detection (external standard method) LNG was monitored at 242 nm, while EED was
detected with fluorescence detector at 310 nm (excitation 285 nm). 
The methods’ performances were fully validated by a determination of linearity, reproducibility, accuracy and sensitivity. Both
methods were applied for determination of Uniformity of Dosage Units. The results obtained with both methods were highly compara-
ble. However, the HPLC method with UV/ fluorescence detection has showed superior sensitivity for EED indicated by 83 times lower
detection limit. 
HPLC method with UV/ fluorescence detection could be recommended as a method of choice for determination of ethinylestradi-
ol, present at a very low dosage level in low-dose oral contraceptives, that also contain bigger amount of synthetic progestin.
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Fig. 1. Structure 
of ethinylestradiol (EED)
Fig. 2. Structure 
of levonorgestrel (LNG)
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Therefore, the modern low-dose oral contraceptives
require a sensitive, accurate and rapid methods of quantita-
tive determination which is unaffected by the small amount
of the estrogen and the large excess of progestogen.
There are several reports (4-13) on determination of EED
and LNG, including the use of derivative spectrometry (4),
high performance liquid chromatography with fluorescence
detection (5), gas chromatography-mass spectrometry on the
pentafluorobenzoyl derivatives (6) and pentafluorobenzyl-
trimethylsilyl derivatives (7), solid phase extraction fol-
lowed by gas chromatography /MS/MS after derivatization
with mixture of N-methyl-N-(trimethylsilyl)-trifluoroac-
etamide, trimethylsilylimidazole, and dithioerytrol (8), solid
phase extraction followed by liquid chromatography-diode
array detection-mass spectrometry (9, 10), affinity chro-
matography with tripeptide column (11), etc. Although the
listed methods give high sensitivity, they still have draw-
backs, including time consuming in extraction process when
solid phase extraction is performed. Furthermore, the target
analytes have to be derivatized if GS-MS is used which
makes these procedures unsuitable for routine analysis.
Additionally, spectrometry is susceptible to much interfer-
ence of excipients, degradation products, and impurities.
On the contrary, liquid chromatography (LC) has only
been employed in a few occasions (12, 13) regardless of its
advantages over the already mentioned techniques. Thus,
unlike GC-MS, LC enables determination of steroid without
derivatization and it is not limited by such factors as properties
of the substances (non volatile) and high molecular weight.
The aim of this research was standardization of HPLC
methods for quantitative determination of associations of
ethinylestradiol (ETE) - levonorgestrel (LNG) in commer-
cially available oral contraceptives.
Experimental
HPLC instrumentation and conditions
HPLC analyses were performed using a Schimadzu LC-
2010 chromatographic system (Schimadzu, Kyoto, Japan)
consisting of a LC-20AT Prominence liquid chromatograph
pump with DGU-20A5 Prominence degasser, a SPD-M20A
Prominence Diode Array Detector, RF 10AXI fluorescence
detector and a SIL-20 AC Prominence auto sampler. Data
analyses were done using Class VP 7.3 Software.
Chromatographic separation was performed on a Puro-
spher® STAR RP-18e reversed-phase column (150 X 4.0 mm
I.D.; particle size 5 µm), in an isocratic mode with a mobile
phase constituted of 47% acetonitrile: 53% water (V/V).
The elution was carried out at a flow rate of 1.50 ml /min.
The injection volume was 10 μl. All analyses were per-
formed at room temperature (24 +/- 2 degrees C). In the UV
method the column effluent was quantified at a wave-
length of 215 nm with drospirenone used as an internal stan-
dard. In the method with UV / fluorescent detection, LNG
was quantified at a wavelength of 242 nm, while EED was
quantified with fluorescent detection (excitation 285 nm/
emission 310 nm).
Preparation of solutions
Commercially available samples, coated tablets con-
taining 30 μg of EED and 150 μg of LNG, were used in this
research. Levonorgestrel, ethinylestradiol and internal
standard were supplied by Schering Deutschland GmbH
(Berlin, Germany). HPLC-grade acetonitrile was from Merck
(Darmstadt, Germany). Double-distilled water was used
to prepare mobile phase solutions.
A solvent was prepared by mixing 60 volumes of ace-
tonitrile and 40 volumes of water. An internal standard solu-
tion used in the HPLC method with UV detection was prepa-
red by dissolving an appropriate amount of drospirenone in
solvent in order to obtain final concentration of 50.0 μg/ml.
All solvents and solutions for HPLC analysis were
filtered through a membrane filter (0.45 μm pore size) and
vacuum degassed before use. 
Calibration curves
Stock solution of EED was prepared by dissolving
Ethinylestradiol standard substance (25 mg) with 100 ml sol-
vent in a 100-ml volumetric flask. Standard solutions were
prepared by dilution of EED stock solution with solvent to
obtain final concentrations ranging from 3.75 μg/ml – 15.0
μg/ml (in the method with UV detection) and 0.6 μg/ml –
3.0 μg/ml (in the method with UV / fluorescence detection).
Stock solution of LNG was prepared by dissolving
Levonorgestrel standard substance (65 mg) with 100 ml sol-
vent in a 100-ml volumetric flask. Standard solutions were
prepared by dilution of LNG stock solution with solvent to
obtain final concentrations ranging from 18.75 μg/ml – 75.0
μg/ml (in the method with UV detection) and 3.0 μg/ml –
15.0 μg/ml (in the method with UV / fluorescence detection).
Sample preparation
In the HPLC method with UV detection, internal stan-
dard method, each of 10 tablets was transferred in 5-ml
volumetric flask and 4 ml internal standard solution was
added. The solution was heated at 60°C in an ultrasonic
bath for 25 minutes, cooled and filtered through 0.45 μm-
nylon syringe filter. 10 μl of the clear solution was injected
into chromatograph.
In the HPLC method with UV/ fluorescence detection,
external standard method, each of 10 tablets was transfer-
red in 25-ml volumetric flask and 20 ml solvent was added.
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The solution was heated at 60°C in an ultrasonic bath for
25 minutes, cooled, filled up with the solvent and filtered
through 0.045 μm-nylon syringe filter. 10 μl of the clear
solution was injected into chromatograph.
Recovery tests 
To study the accuracy of the proposed analytical meth-
ods, recovery tests were conducted using the standard addi-
tion method. To discover whether excipients interfered with
the analysis, known amounts of standard were added to
tablet formulation samples and the resulting mixtures were
analyzed by the proposed methods. The percent of recov-
ery was calculated using the calibration equation. 
Results and discussion
HPLC method with UV detection, internal standard
method
In the preliminary research, the absorption spectra of
EED and LNG in solvent were studied. The UV spectrum
characteristic of the EED presents two maxima, one at 215
nm and another at 280 nm, due to π?π* transitions in the
aromatic ring (14). LNG shows a characteristic absorption
maximum at 242 nm which arises from π?π* transitions
(in this case in the conjugated α, β-unsaturated ketone
(C=C-C (O)-C) at position 3 (23). As both analyzed com-
pounds absorb almost equally at a wavelength of 215 nm,
this wavelength was chosen as the most adequate for a
simultaneous detection of EED and LNG in a mixture.
British Pharmacopoeia (BP) (15) separation method for
Ethinylestradiol and Levonorgestrel Tablets, two active com-
ponents in contraceptive tablets, uses a reversed-phase col-
umn (15 cm x 4.6 mm) packed with octadecyl silica gel (par-
ticle size 5 μm) and a mobile phase consisting of 49% ace-
tonitrile and 51% water, with a flow rate of 1.5 ml per minute
and a detection wavelength of 215 nm. 2-hydroxybiphenyl
was recommended as an internal standard. As 2-hydroxybi-
phenyl was not available at the time of performing the
analysis, we have modified the proposed method by choos-
ing another substance as an internal standard.
There are a few substances cited in the literature as in-
ternal standards in the determination of EED and LNG, such
as: buthyl-hydroxytoluene (16), hydrocortisone (17) and dros-
pirenone (13). However, the results we have obtained with
buthyl-hydroxytoluene and hydrocortisone were not satis-
factory. Namely, the elution of hydrocortisone was too fast,
and buthyl-hydroxytoluene showed low absorptivity at the
wavelength of 215 nm. Finally, drospirenone has fulfilled
all conditions to be used as an internal standard.
Chromatograms that represent the separation of EED
and LNG (with drospirenone as an internal standard) in
mixed standard solution and sample solution with UV de-
tection at wavelength of 215 nm are shown in Fig. 3. and
Fig. 4, respectively.
System suitability test is an integral part of the liquid
chromatographic method. System repeatability was estima-
ted by 10 repeated injections of mixed standard solution at
100% of test concentration (7.5 μg/ml EED, 37.5 μg/ml LNG,
50.0 μg/ml IS). The variation in retention times among 10
replicate injections was very low with RSD values: 0.21%
for EED, 0.22% for internal standard, and 0.23% for LNG.
The variation in peak areas among 10 replicate injections was
also low with RSD values: 0.39% for EED, 0.19% for inter-
nal standard, and 0.20% for LNG. These results are in accor-
dance with European Pharmacopoeia (2). The data obtained
from system suitability test are presented in Table 1.
The linearity of EED and LNG were established from a
series of standard solutions for both EED and LNG separa-
tely, with concentrations ranging from 50% to 250% of the
test concentration. Good linearity was observed for both
analyzed compounds (r2 = 0,9999 for both EED and LNG).
The limit of detection (LOD) and the limit of quantifica-
tion (LOQ) were calculated according to ICH Guideline
(18). LOD for EED was 0.0538 µg/ml, while LOQ for
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Fig. 3. A typical chromatogram of mixed standard solution 
(7.5 µg/ml EED, 37.5 µg/ml LNG, and 50.0 µg/ml internal 
standard) detected by UV detector at a wavelength of 215 nm
Fig. 4. A typical chromatogram of a sample solution detected by 
UV detector at a wavelength of 215 nm
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Method UV detection1 UV / fluorescence detection2 
Parameter EED IS LNG EED LNG 
Capacity factor (k′) 4.349 6.392 7.487 4.147 7.027 
Selectivity factor  (α)3 α 2/1 = 1.470 α 3/2 = 1.171 α ‘2/1 = 1.694 
Theoretical plates 3835 5607 6108 4175 6654 
Resolution4 R2/1 = 5.517 R3/2 = 2.640 R’2/1 = 8.087 
Symmetry factor 1.10 0.95 1.07 1.09 1.11 
Table 1. System suitability test parameters, comparative data between two methods
1 HPLC method with UV detection at wavelength of 215 nm (for both levonorgestrel and ethinylestradiol), internal standard method
2 HPLC method with UV detection at wavelength of 242 nm (for levonorgestrel) and fluorescence detection at 310 nm (excitation at 285 nm) (for ethinylestradiol), external standard method
3 α2/1: selectivity factor between EED peak and IS (internal standard) peak; α3/2; selectivity factor between IS (internal standard) peak and LNG peak; α'2/1; selectivity factor between EED 
peak and LNG peak;
4 R2/1: resolution between EED peak and IS (internal standard) peak; R3/2: resolution between IS (internal standard) peak and LNG peak; R'2/1: resolution between EED peak and LNG peak
 
EED LNG 
 
UV detection1 UV / florescence detection2 UV detection
1 UV / florescence detection2 
Concentration range (ìg/ml) 3.75 – 18.75 0.6 – 3.0 18.75 – 93.75 3.0 – 15.0 
Slope 4.4489 2213460 2.1364 21504 
Intercept 0.0276 9795 0.0113 1299.2 
Correlation coefficient (r2) 0.9999 1 0.9999 0.9998 
Limit of detection (µg/ml) 5.38 x 10-2 6.5 x 10-4 7.84 x 10-2 3.81 x 10-2 
Limit of quantification (µg/ml) 0.1629 1.97 x 10-3 0.2378 0.1156 
Table 2. Linearity, comparative data between two methods
1 HPLC method with UV det ection at wavelength of 215 nm (for both levonorgestrel and ethinylestradiol), internal standard method
2 PLC method with UV detection at wavelength of 242 nm (for levonorgestrel) and fluorescence detection at 310 nm (excitation at 285 nm) (for ethinylestradiol), 
external standard method
UV detection1 UV / fluorescence detection2  
 EED (ìg/tabl.) % of label claim EED (ìg/tabl.) % of label claim 
   X  28.7372 95.79 28.9262 96.42 
   SD 0.4643 1.5477 0.2588 0.8626 
   RSD (%)  1.62  0.89 
   Confidence interval (95%) 28.250 – 29.225 ìg/tabl. 94.17 % – 97.42 % 
28.654 – 29.198 ìg/tabl. 
95.51 % – 97.33 % 
 LNG (ìg/tabl.) % of label claim LNG (ìg/tabl.) % of label claim 
   X  143.2109 95.47 141.3786 94.25 
   SD 1.1562 0.7708 1.2835 0.8556 
   RSD (%)  0.81  0.91 
   Confidence interval (95%) 142.000 – 144.420 ìg/tabl. 94.67 % – 96.28 % 
140.030 – 142.73 ìg/tabl. 
93.35 % – 95.15 % 
Table 3. Precision, comparative data between two methods
1 HPLC method with UV detection at wavelength of 215 nm (for both levonorgestrel and ethinylestradiol)
2 HPLC method with UV detection at wavelength of 242 nm (for levonorgestrel) and fluorescence detection at 310 nm (excitation at 285 nm) 
(for ethinylestradiol)
EED was 0.1629 µg/ml. LOD for LNG was 0.0784 µg/ml,
and LOQ for LNG was 0.2378 µg/ml (Table 2.).
The precision of the analytical method was assessed
using 6 determinations at 100% of test concentration that
were done on the same day, by the same analyst and using
the same equipment. Intermediate precision was estab-
lished by repeating the procedure in two different days by
the same analyst. The relative standard deviations (< 2%)
confirmed precision of the method. The statistical data are
shown in Table 3. 
The recovery tests were performed according to the
recommendation of ICH Guideline (17). Satisfactory
recoveries were observed for both EED and LNG (99.57%
± 1.55%, and 98.86 % ± 1.19%, for EED and LNG, respect-
ively). The results obtained are shown in Table 5 and they
confirmed the accuracy of the method.
The proposed method was applied to analyze the para-
meter Uniformity of Dosage Units in the commercially
available samples (coated tablets containing 30 µg of ETE
and 150 µg of LNG). The obtained results were in good
agreement with the certified values and were in accordance
with European Pharmacopoeia requirements. The results
obtained are shown in Table 5.
HPLC method with UV / fluorescence detection, external
standard method
During the development of the analytical method for
quantification of the active compound in Levonorgestrel
and Ethinylestradiol tablet we have been faced with two
inherent problems. They were: a) the low ultraviolet molar
absorptivity of EED; and b) the low proportion of EED
compared to LNG in the pharmaceutical formulation.
Fortunately, the molecule of EED has ability to fluores-
cence (emit higher wavelength radiation) after excitation
by shorter wavelength energy, which allowed us to measure
the concentration of EED with fluorescence detector. On
the contrary, levonorgestrel has no natural fluorescence.
Because of that, we have chosen to measure the UV absor-
bance of levonorgestrel at 242 nm and the fluorescence of
EED at 310 nm (excitation at 285 nm) using a DAD de-
tector connected in series with a fluorescence detector.
As the fluorescence detector is much more sensitive than
UV detector (10-1000 times more sensitive, depending on the
compound being measured), we had to dilute the sample solu-
tion to obtain the optimal test concentration. Preliminary tests
were performed in order to define the concentration interval in
which the intensity of the detector response is proportional to
the concentration of the analyzed substance. Standard solu-
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 UV detection1 UV / fluorescence detection2  
 Added amount (μg/ml) 
Found amount3 
(μg/ml) Recovery (%) 
Added amount 
(μg/ml) 
Found amount3 
(μg/ml) Recovery (%) 
EED 1.84 1.79 97.37 0.308 0.307 99.93 
 3.69 3.73 101.19 0.615 0.608 98.82 
 5.53 5.60 101.25 0.923 0.925 100.20 
 7.37 7.38 100.10 1.231 1.237 100.53 
 9.21 9.13 99.08 1.539 1.536 99.85 
 11.06 10.88 98.43 1.846 1.842 99.78 
X  ± SD  99.57 ± 1.55   99.85 ± 0.57 
RSD (%)  1.56   0.58 
LNG 9.54 9.21 97.14 1.522 1.576 103.52 
 19.08 19.43 100.48 3.044 2.989 98.19 
 28.61 28.67 99.01 4.566 4.556 99.77 
 38.15 38.00 98.68 6.088 6.058 99.51 
 47.69 47.99 98.98 7.610 7.641 100.41 
 57.23 56.97 99.96 9.132 9.138 100.06 
X  ± SD  98.86 ± 1.19   100.24 ± 1.78 
RSD (%)  1.20   1.77 
Table 4. Accuracy, comparative data between two methods
1 HPLC method with UV detection at wavelength of 215 nm (for both levonorgestrel and ethinylestradiol)
2 HPLC method with UV detection at wavelength of 242 nm (for levonorgestrel) and fluorescence detection at 310 nm (excitation at 285 nm) 
(for ethinylestradiol)
3  Average of three determinations
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tions of EED concentration ranging from 0.12 μg/ml-12.0
μg/ml were measured and the linearity was proven through
the range 0.12 μg/ml – 4.8 μg/ml. Therefore, the concentra-
tion of 1.2 μg/ml was chosen as optimal test concentration. 
A chromatogram that represents the separation of EED
and LNG in mixed standard solution and sample with UV/
fluorescence detection is shown in Fig. 4. and Fig. 5., res-
pectively.
System repeatability was estimated by 10 repeated
injections of mixed standard solution at 100% of test con-
centration (1.2 μg/ml EED, 6.0 μg/ml LNG). The variation
in retention times among 10 replicate injections was very low
with RSD values: 0.37% for EED and 0.41% for LNG. The
variation in peak areas among 10 replicate injections was
also low with RSD values: 0.25% for EED and 0.23% for
LNG. These results are in accordance with European
Pharmacopoeia (2). The data obtained from system suita-
bility test are presented in Table 1.
An excellent linearity was observed for both analyzed
compounds (r2 = 1 for EED and 0.9998 for LNG). The limit
of detection (LOD) for EED was 0.00065 μg/ml and the
limit of quantification (LOQ) for EED was 0.00197 μg/ml.
LOD for LNG was 0.0381 μg/ml (Table 2.).
It is obvious that HPLC method with fluorescence
detection, external standard method, is about 83 times
more sensitive for EED determination than HPLC method
with UV detection, internal standard method (LODFLUO =
0.00065  g/ml vs. LODUV = 0.0538 g/ml). Moreover, the
use of wavelength of maximum absorbance for LNG de-
tection (242nm) in the HPLC method with UV/fluores-
cence detection, external standard method, also enhances
the sensitivity for LNG determination in comparison to the
HPLC method with UV detection, internal standard method,
where a wavelength of 215 nm is used (LOD242nm =
0.0381 μg/ml vs. LOD215 nm = 0.0785 μg/ml).
The precision of the method was validated by perform-
ing 6 determinations at 100% of test concentration that were
done on the same day, by the same analyst and using the same
equipment. Intermediate precision was established by repe-
Fig. 5. A typical chromatogram of mixed standard solution 
(1.2 mg/ml EED and 6.0 9 ptg/ml LNG) detected by UV
detector at a wavelength of 242 nm (for LNG) and 
fluorescence detector at a wavelength of 310 nm 
(excitation at 285 nm) (for EED)
Fig. 6. A typical chromatogram of a sample solution detected by 
UV detector at a wavelength of 242 nm (for LNG) and 
fluorescence detector at a wavelength of 310 nm 
(excitation at 285 nm) (for EED)
UV detection1 UV / fluorescence detection2  
 EED (ìg/tabl.) % of label claim EED (ìg/tabl.) % of label claim 
X  28.5813 95.27 28.9087 96.36 
SD  2.29  1.94 
AV  8.73  6.78 
 LNG (ìg/tabl.) % of label claim LNG (ìg/tabl.) % of label claim 
X  145.2815 96.85 145.7140 97.14 
SD  1.38  2.39 
AV  6.78  7.10 
Table 5. Uniformity of dosage units, comparative data between two methods
1  HPLC method with UV detection at wavelength of 215 nm (for both levonorgestrel and ethinylestradiol)
2 HPLC method with UV detection at wavelength of 242 nm (for levonorgestrel) and fluorescence detection at 310 nm (excitation at 285 nm) 
(for ethinylestradiol)
3 Average of three determinations
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ating the procedure in two different days by the same ana-
lyst. The variation in results obtained among 6 determina-
tions was very low (< 2%), which confirmed precision of the
method. The statistical data are shown in Table 3.
Satisfactory recoveries were observed for both EED and
LNG (99.85% ± 0.57% and 100.24% ± 1.78%, for EED and
LNG, respectively). The results are shown in Table 5.
The HPLC method with UV/ fluorescence detection,
external standard method, was applied to analyze the para-
meter Uniformity of Dosage Units in the commercially
available samples (coated tablets containing 30 µg of ETE
and 150 µg of LNG). The results were in good agreement
with the declared values and in accordance with European
Pharmacopoeia requirements. The results obtained are shown
in Table 5.
Conclusion
Both of the proposed HPLC method enables simple,
accurate, precise and rapid determination of EED and LNG
in pharmaceutical dosage forms without interference from
excipients and could, therefore, be easily adopted in routine
quality control analysis. The methods' performances were
fully validated by determination of linearity, reproducibili-
ty, accuracy and sensitivity. The methods were applied for
determination of Uniformity of Dosage Units. The results
obtained with both proposed methods were highly compa-
rable. However, in the case of sensitivity, the HPLC method
with UV/ fluorescence detection, external standard method,
showed superior sensitivity, which was indicated by lower
detection limit for EED and LNG. By applying fluorescen-
ce detection at 310 nm (excitation at 285 nm) LOD for EED
was about 83 times lower than with UV detection at 215
nm (LODFLUO = 0.00065 μg/ml / LODUV = 0.0538 μg/ml).
Furthermore, we have also obtained a better sensitivity for
LNG using a wavelength of maximum absorbance for LNG
(242 nm) instead of a wavelength of 215 nm (LOD242nm
= 0.0381 μg/ml / LOD215 nm = 0.0785 μg/ml).
The sensitivity of HPLC method with UV/ fluorescence
detection is its main advantage and it could be recommend-
ed as the method of choice for determination of ethinyl-
estradiol, present at a very low dosage level in low-dose
oral contraceptives.
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Rezime
Opredeluvawe na etinilestradiol i levonorgestrel vo peroralni 
kontraceptivni tableti so HPLC metodi so UV
i UV/fluorescentna detekcija
Klu~ni zborovi: etinilestradiol, levonorgestrel, HPLC, peroralni kontraceptivi
Niskodoziranite peroralni kontraceptivi sodr`at dve aktivni komponenti: estrogen hormon (prisuten vo mno-
gu mala koli~ina) i sintetski progestogen (prisuten vo 5-30 pati pogolema koli~ina). Zaradi vakviot soodnos,
potreben e senzitiven, to~en i brz metod za istovremeno opredeluvawe na dvete aktivni komponenti.
Razvieni se HPLC metodi za opredeluvawe na etinilestradiol (EED) i levonoregestrel (LNG) vo kontracep-
tivni tableti. Razdojuvaweto na komponentite vo dvete metodi be{e izvedeno na reverzno fazna kolona Purospher®
STAR RP-18e (150 X 4.0 mm I.D.; 5 µm), so mobilna faza sostavena od 47% acetonitril i 53% voda (V/V), izokratno, so
brzina na protok – 1,50 ml /min. Vo HPLC metodot so UV detekcija (metod na vnatre{en standard) detekcijata na
dvete komponenti be{e izvedena na 215 nm. Kako interen standard be{e upotreben drospirenon. Vo HPLC metodot so
UV/fluorescentna detekcija (metod na nadvore{en standard), LNG se detektira na 242 nm, a EED so fluorescen-
ten detektor na 310 nm (ekscitacija na 285 nm). 
Metodite bea kompletno validirani preku opredeluvawe na linearnost, reproducibilnost, to~nost i senzi-
tivnost. Dvata metoda bea primeneti za opredeluvawe na parametarot “voedna~enost na dozirani edinici”, pri
{to se dobieni sporedlivi rezultati. No, HPLC metodot so UV/fluorescentna detekcija e mnogu posenzitiven za opre-
deluvawe na EED, {to se potvrduva so 83 pati poniskata vrednost na limit na detekcija za EED.
Na HPLC metodot so UV/fluorescentna detekcija mu se dava prednost kako metod od izbor pri kontrola na kva-
litetot na niskodozirani peroralni kontraceptivi so EED vo kombinacija so progestogeni aktivni komponenti,
prisutni vo povisoki koncentracii.
